MaSTerCell S.A. Announces Creation of a new Commercial Manufacturing facility for Cell & Gene Therapies

Masthercell announces today that it has signed a lease agreement for a 5.700 m² facility located in Gosselies. The new facility will become a state-of-the-art manufacturing and production site designed for late-stage and commercially-approved cell and gene therapy products. The commercial facility is expected to be operational in early 2021. Discover the press release here.

Read more

Graftys raises capital of €4.1M

Graftys, a world leader in resorbable bone cements, announces the completion of a €4.1M funding round, the development of its operations in Wallonia and the reinforcement of its French operations. Discover the press release here.

Read more